DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma

Epigenomics

Volumn 7, Issue 4, 2015, Pages 581-592

  Zhang, Xiaolei ^a   Liu, Shuang ^b   Shen, Congle ^a   Wu, Yali ^a   Zhang, Ling ^c   Chen, Xiangmei ^a   Lu, Fengmin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Henan Cancer Hospital   (China)

Author keywords

cancer stem cells; HBV DNA integration; hepatocellular carcinoma; methylation; recurrence

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURGERY; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ISOLATION; ADULT; AGED; CANCER OF UNKNOWN PRIMARY SITE; GENETICS; HEPATITIS B VIRUS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR CELL LINE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

HEPATITIS B VIRUS;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; NEOPLASTIC STEM CELLS; VIRUS INTEGRATION;

EID: 84933525671     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.23     Document Type: Article

References (38)

1. Vivarelli M, Montalti R, Risaliti A. Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World J. Gastroenterol. 19(42), 7316-7326 (2013).
2. Yazici C, Niemeyer DJ, Iannitti DA, Russo MW. Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev. Gastroenterol. Hepatol. 8(1), 63-82 (2014).
3. Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J. Am. Coll. Surg. 201(5), 663-670 (2005).
4. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br. J. Surg. 99(12), 1622-1629 (2012).
5. Dhir M, Lyden ER, Smith LM, Are C. Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis. HPB (Oxford) 14(9), 635-645 (2012).
6. Arii S, Teramoto K, Kawamura T et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J. Hepatobiliary Pancreat. Surg. 8(5), 397-403 (2001).
7. Choi GH, Kim DH, Kang CM et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann. Surg. Oncol. 15(2), 618-629 (2008).
8. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 414(6859), 105-111 (2001).
9. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8(10), 755-768 (2008).
10. Kyo S, Maida Y, Inoue M. Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions. Cancer Lett. 308(2), 123-133 (2011).
11. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 6(6), 339-351 (2009).
12. Fan ST, Yang ZF, Ho DW, Ng MN, Yu WC, Wong J. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann. Surg. 254(4), 569-576 (2011).
13. Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 29(5), 1446-1452 (1999).
14. Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J. Pathol. 199(3), 345-353 (2003).
15. He B, Tang ZY, Liu KD, Zhou G. Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype. J. Cancer Res. Clin. Oncol. 122(12), 763-766 (1996).
16. Xu X, Xing B, Hu M et al. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy. Cytotherapy 12(2), 190-200 (2010).
17. Wang Y, Cheng J, Xu C et al. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma. Liver Int. 32(3), 420-428 (2012).
18. Jiang S, Yang Z, Li W et al. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS ONE 7(9), e40363 (2012).
19. Yang XR, Xu Y, Yu B et al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59(7), 953-962 (2010).
20. Goeppert B, Schmezer P, Dutruel C et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 52(6), 2023-2033 (2010).
21. Moribe T, Iizuka N, Miura T et al. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Int. J. Oncol. 33(5), 949-958 (2008).
22. Moribe T, Iizuka N, Miura T et al. Methylation of multiple genes as molecular markers for diagnosis of a small, welldifferentiated hepatocellular carcinoma. Int. J. Cancer 125(2), 388-397 (2009).
23. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology 56(3), 994-1003 (2012).
24. Yu J, Tao Q, Cheung KF et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48(2), 508-518 (2008).
25. Xie B, Zhou J, Yuan L et al. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma. Hum. Pathol. 44(5), 795-801 (2013).
26. Ammerpohl O, Pratschke J, Schafmayer C et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer. 130(6), 1319-1328 (2012).
27. Ren J, He W, Zhang R et al. RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alphafetoprotein level. J Huazhong Univ Sci Technolog Med Sci. 29(3), 309-312 (2009).
28. Kuo CC, Lin CY, Shih YL et al. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas. Clin. Chem. Lab. Med. 52(8), 1235-1245 (2014).
29. Tao R, Li J, Xin J et al. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS ONE 6(5), e19862 (2011).
30. Xu XL, Xing BC, Han HB et al. The properties of tumorinitiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Carcinogenesis 31(2), 167-174 (2010).
31. Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells. Liver Cancer 3(2), 71-84 (2014).
32. Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J. Gastroenterol. 20(8), 2098-2106 (2014).
33. Yin X, Li YW, Jin JJ et al. The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma. Oncol. Lett. 5(4), 1155-1162 (2013).
34. Yin X, Li YW, Zhang BH et al. Coexpression of stemness factors Oct4 and Nanog predict liver resection. Ann. Surg. Oncol. 19(9), 2877-2887 (2012).
35. Arzumanyan A, Friedman T, Ng IO, Clayton MM, Lian Z, Feitelson MA. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res. 71(10), 3701-3708 (2011).
36. Kimura O, Kondo Y, Kogure T et al. Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma. Biomed. Res. Int. 2014, 172913 (2014).
37. Yasui M, Harada A, Nonami T et al. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis. World J. Surg. 21(8), 860-865 (1997).
38. Kaibori M, Matsui Y, Saito T, Kamiyama Y. Risk factors for different patterns of recurrence after resection of hepatocellular carcinoma. Anticancer Res. 27(4C), 2809-2816 (2007).